Analysis Note
Positive ControlHep G2 or NIH 3T3 cells
Application
Frozen Sections (5-10 µg/ml)r>Immunoblotting (1-5 µg/ml)r>Immunofluorescence (1-5 µg/ml)r>Immunoprecipitation (1-2 µg per reaction)r>Paraffin Sections (5-10 µg/ml, heat or pepsin pre-treatment required)r>Gel Shift (see comments and application references)r>Free-floating Sections (not recommended)
General description
This Anti-c-Fos (Ab-2) (4-17) Rabbit pAb is validated for use in Frozen Sections, WB, IF, IP, Paraffin Sections, Gel Shift, for the detection of c-Fos (Ab-2) (4-17).
The proto-oncogene fos has been implicated in cell growth, differentiation and development. fos is induced by a large number of stimuli including mitogens, differentiation-specific agents, pharmacological agents, etc. Induction of the 62,000 dalton fos protein is rapid but transient. The fos protein is associated with a 39,000 dalton protein which has been identified as the protein product of the jun proto-oncogene (c-jun). The fos/jun protein complex binds specifically to a sequence element in DNA referred to as the AP-1 binding site.
Immunoaffinity purified rabbit polyclonal antibody. Recognizes the ~50-62 kDa c-Fos protein.
Recognizes the ~50-62 kDa c-Fos protein in HepG2, NIH3T3, and MCF-7 cells.
Immunogen
a synthetic peptide (SGFNADYEASSSRC) (Cat. No. PP10) corresponding to amino acids 4-17 of human c-Fos
Human
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
For gel shift assays resuspend in 100 µl of buffer. The immunogen, c-fos (Peptide-2), Cat. No. PP10, is also available for competition studies (see Murphy, et al. below). Antibodies should be titrated for optimal results in individual systems.
DeTogni, P., et al. 1988. Cell Biol.8, 2251.Rouscher III, F.J., et al. 1988. Science240, 1010.Sassone-Corsi, P., et al. 1988. Cell54, 553.Verma, I.M. and Graham, W.R. 1987. Cancer Res.49, 29.Verma, I.M. and Sassone-Corsi, P. 1987. Cell51, 513.Muller, R. 1986. Biochim. Biophys. Acta823, 207.Verma, I. 1986. Trends Genet.2, 93.Greenberg, M. and Ziff, E. 1984. Nature (London), 311, 433
Packaging
100 µg in Glass bottle
Physical form
Lyophilized from PBS, a volatile buffer, 100 µg BSA.
Reconstitution
Resuspend the lyophilized antibody with sterile phosphate buffered saline (PBS), pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4, to yield a final concentration of 100 µg/ml; product will be more stable if 0.1% sodium azide is included (do not add azide if antibody is to be used with viable cells). Lyophilized antibodies should be resuspended at 4°C with occasional gentle mixing.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: